- Avacopan jako přídatná terapie ANCA asociované vaskulitidy2020 | First Faculty of Medicine
- Avacopan in the treatment of ANCA-associated vasculitis2018 | First Faculty of Medicine
- Avacopan - nová možnost v léčbě ANCA asociované vaskulitidy?2021 | First Faculty of Medicine
- Avacopan, inhibitor receptoru pro složku C5a komplementu, může nahradit kortikosteroidy v indukční léčbě pacientů s ANCA asociovanou vaskulitidou : komentář2017 | First Faculty of Medicine
- Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis2017 | First Faculty of Medicine
- Complement Inhibition in ANCA-Associated Vasculitis2022 | First Faculty of Medicine
- Novel trends in monitoring and therapy of ANCA associated vasculitides2018 | First Faculty of Medicine
- Management of antineutrophil cytoplasmic antibody-associated vasculitis with glomerulonephritis as proposed by the ACR 2021, EULAR 2022 and KDIGO 2021 guidelines/recommendations2023 | First Faculty of Medicine